A preliminary and comparative evaluation of a novel Ad5 [E1-, E2b-] recombinant-based vaccine used to induce cell mediated immune responses
Elizabeth S. GabitzschEtubics Corporation, Seattle, WA, United States. [email protected]Younong XuEtubics Corporation, Seattle, WA, United StatesLois H. YoshidaEtubics Corporation, Seattle, WA, United StatesJoseph P. BalintEtubics Corporation, Seattle, WA, United StatesRichard B. GayleEtubics Corporation, Seattle, WA, United StatesAndrea AmalfitanoDepartment of Microbiology and Molecular Genetics, Michigan State University, East Lansing, MI, United StatesFrank R. JonesEtubics Corporation, Seattle, WA, United States
2008en
ABI
Abstract
No abstract available.
Identifiers
Citations and references
Cited by 20 references